其他
Cytosorbents(CTSO)04-20 05:05
$Cytosorbents(CTSO)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-049524 Act: 34 Size: 15 MB 网页链接
简介:Cytosorbents Corporation于2002年4月25日在内华达州注册成立。该公司是重症监护运用血液净化调节炎症的集中免疫治疗公司,以预防或治疗危及生命的多器官衰竭为目标。该技术是基于生物相容的,高度多孔的聚合物吸附剂的珠子,其能够提取血液和其它体液中不需要的物质。该技术是受32项美国专利的保护。
今开:0.99 | 昨收:1.01 |
最高:1 | 最低:0.95 |
涨停价: | 跌停价: |
总市值:53757920 |
Cytosorbents(CTSO)04-20 05:05
$Cytosorbents(CTSO)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-049524 Act: 34 Size: 15 MB 网页链接
Cytosorbents(CTSO)06-11 04:35
$Cytosorbents(CTSO)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-070039 Act: 34 Size: 212 KB 网页链接
Cytosorbents(CTSO)04-20 04:55
$Cytosorbents(CTSO)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-049498 Act: 34 Size: 1 MB 网页链接
Cytosorbents(CTSO)04-20 05:05
$Cytosorbents(CTSO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-049520 Act: 34 Size: 416 KB 网页链接
Cytosorbents(CTSO)05-10 04:25
$Cytosorbents(CTSO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000703 Act: 34 Size: 6 MB 网页链接
Cytosorbents(CTSO)05-10 05:25
$Cytosorbents(CTSO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-059457 Act: 34 Size: 324 KB 网页链接
Cytosorbents(CTSO)07-05 18:05
$Cytosorbents(CTSO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-24-077866 Act: 34 Size: 831 KB 网页链接
Cytosorbents(CTSO)05-07 05:05
$Cytosorbents(CTSO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001104659-24-057514 Act: 34 Size: 357 KB 网页链接
Cytosorbents(CTSO)05-23 04:45
$Cytosorbents(CTSO)$ 8-K Current report, item 3.01 Accession Number: 0001104659-24-064300 Act: 34 Size: 198 KB 网页链接
鲜克有终72021-08-12 19:14
$Cytosorbents(CTSO)$ fda授予公司产品突破性设备称号查看全文
细胞生物2021-08-12 16:26
$Cytosorbents(CTSO)$ 美股血液灌流器查看全文
令狐不冲9992021-01-12 22:13
1.12盘前异动$Akerna(KERN)$ $Cytosorbents(CTSO)$ $普拉格能源(PLUG)$查看全文
令狐不冲9992021-01-04 21:57
H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
美股滚雪球2020-01-29 10:39
$Cytosorbents(CTSO)$ $幸福来(HAPP)$ 一堆股票蹭疫情概念。$美团点评-W(03690)$查看全文
刀刃嗜血2015-06-25 06:50
$CYTOSORBENTS CORP(CTSO)$ 每天稳步10% 啊查看全文
$Cytosorbents(CTSO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-24-077866 Act: 34 Size: 831 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-070039 Act: 34 Size: 212 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, item 3.01 Accession Number: 0001104659-24-064300 Act: 34 Size: 198 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-059457 Act: 34 Size: 324 KB 网页链接
$Cytosorbents(CTSO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000703 Act: 34 Size: 6 MB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001104659-24-057514 Act: 34 Size: 357 KB 网页链接
$Cytosorbents(CTSO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-049520 Act: 34 Size: 416 KB 网页链接
$Cytosorbents(CTSO)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-049524 Act: 34 Size: 15 MB 网页链接
$Cytosorbents(CTSO)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-049498 Act: 34 Size: 1 MB 网页链接
$Cytosorbents(CTSO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043790 Size: 9 KB 网页链接